| Reference |
|---|
Hatch C, Piombo S, Fang J, Gach J, Ewald M, Van Trigt W, et al. SARS-CoV-2 infection of endothelial cells, dependent on flow-induced ACE2 expression, drives hypercytokinemia in a vascularized microphysiological system. Front Cardiovasc Med. 2024;11:1360364 pubmed publisher |
Subramaniyan B, Gurung S, Bodas M, Moore A, Larabee J, Reuter D, et al. The Isolation and In Vitro Differentiation of Primary Fetal Baboon Tracheal Epithelial Cells for the Study of SARS-CoV-2 Host-Virus Interactions. Viruses. 2023;15: pubmed publisher |
Wang L, Wang S, Wu L, Li W, Bray W, Clark A, et al. PCIF1-mediated deposition of 5'-cap N6,2'-O-dimethyladenosine in ACE2 and TMPRSS2 mRNA regulates susceptibility to SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2023;120:e2210361120 pubmed publisher |
Lindqvist R, Benz C, Sereikaitė V, Maassen L, Laursen L, Jemth P, et al. A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses. Viruses. 2022;14: pubmed publisher |
Forsyth C, Zhang L, Bhushan A, Swanson B, Zhang L, Mamede J, et al. The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells. Microorganisms. 2022;10: pubmed publisher |
Ireland R, Davies C, Keyser E, Findlay J, Eastaugh L, Laws T, et al. Histopathological and Immunological Findings in the Common Marmoset Following Exposure to Aerosolized SARS-CoV-2. Viruses. 2022;14: pubmed publisher |
Xue Y, Yang D, Vogel P, Stabenow J, Zalduondo L, Kong Y, et al. Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19. Viruses. 2022;14: pubmed publisher |
Lee R, Li T, Chang S, Chao T, Kuo C, Pan M, et al. Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2. Int J Mol Sci. 2022;23: pubmed publisher |
Ramal Sanchez M, Castellini C, Cimini C, Taraschi A, Valbonetti L, Barbonetti A, et al. ACE2 Receptor and Its Isoform Short-ACE2 Are Expressed on Human Spermatozoa. Int J Mol Sci. 2022;23: pubmed publisher |
Zeng F, Li Y, Deng Z, He J, Li W, Wang L, et al. SARS-CoV-2 spike spurs intestinal inflammation via VEGF production in enterocytes. EMBO Mol Med. 2022;14:e14844 pubmed publisher |
Yamaguchi T, Hoshizaki M, Minato T, Nirasawa S, Asaka M, Niiyama M, et al. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury. Nat Commun. 2021;12:6791 pubmed publisher |
Tu W, McCuaig R, Melino M, Rawle D, Le T, Yan K, et al. Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication. Cell Discov. 2021;7:37 pubmed publisher |
Miličić Stanić B, Maddox S, de Souza A, Wu X, Mehranfard D, Ji H, et al. Male bias in ACE2 basic science research: missed opportunity for discovery in the time of COVID-19. Am J Physiol Regul Integr Comp Physiol. 2021;320:R925-R937 pubmed publisher |
Bhattacharjee M, Lin J, Chang C, Chiou Y, Li T, Tai C, et al. Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2. Mol Biol Evol. 2021;38:2715-2731 pubmed publisher |
Suresh V, Parida D, Minz A, Sethi M, Sahoo B, Senapati S. Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies. Front Pharmacol. 2020;11:579330 pubmed publisher |
Blume C, Jackson C, Spalluto C, Legebeke J, Nazlamova L, Conforti F, et al. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat Genet. 2021;53:205-214 pubmed publisher |
Lee I, Nakayama T, Wu C, Goltsev Y, Jiang S, Gall P, et al. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs. Nat Commun. 2020;11:5453 pubmed publisher |
Kalidhindi R, Borkar N, Ambhore N, Pabelick C, Prakash Y, Sathish V. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?. Am J Physiol Lung Cell Mol Physiol. 2020;319:L843-L847 pubmed publisher |
Lee I, Nakayama T, Wu C, Goltsev Y, Jiang S, Gall P, et al. Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers. medRxiv. 2020;: pubmed publisher |
Haydn T, Kehr S, Willmann D, Metzger E, Schüle R, Fulda S. Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells. Int J Cancer. 2020;146:3435-3449 pubmed publisher |
Kim D, Nam H, Lee W, Yim H, Ahn J, Park S, et al. PKCα-LSD1-NF-κB-Signaling Cascade Is Crucial for Epigenetic Control of the Inflammatory Response. Mol Cell. 2018;69:398-411.e6 pubmed publisher |
Lobo J, Rodrigues A, Antunes L, Graça I, Ramalho Carvalho J, Vieira F, et al. High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer. Urol Oncol. 2018;36:161.e7-161.e17 pubmed publisher |
Pajtler K, Weingarten C, Thor T, Künkele A, Heukamp L, Buttner R, et al. The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma. Acta Neuropathol Commun. 2013;1:19 pubmed publisher |
Kashyap V, Ahmad S, Nilsson E, Helczynski L, Kenna S, Persson J, et al. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer. Mol Oncol. 2013;7:555-66 pubmed publisher |
Serce N, Gnatzy A, Steiner S, Lorenzen H, Kirfel J, Buettner R. Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast. BMC Clin Pathol. 2012;12:13 pubmed publisher |
Janzer A, Lim S, Fronhoffs F, Niazy N, Buettner R, Kirfel J. Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components. Biochem Biophys Res Commun. 2012;421:665-70 pubmed publisher |
Bennani Baiti I, Machado I, Llombart Bosch A, Kovar H. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. Hum Pathol. 2012;43:1300-7 pubmed publisher |
Schildhaus H, Riegel R, Hartmann W, Steiner S, Wardelmann E, Merkelbach Bruse S, et al. Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum Pathol. 2011;42:1667-75 pubmed publisher |
Kauffman E, Robinson B, Downes M, Powell L, Lee M, Scherr D, et al. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog. 2011;50:931-44 pubmed publisher |
Lim S, Janzer A, Becker A, Zimmer A, Schüle R, Buettner R, et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis. 2010;31:512-20 pubmed publisher |
